HomeProduct Complimentary download KeyGene and Floragenex extend license agreement around KeyGene’sSequence Based Genotypingtechnology

KeyGene and Floragenex extend license agreement around KeyGene’sSequence Based Genotypingtechnology

Keyword:
Publish time: 28th July, 2015      Source: Wageningen, The Netherlands andPortland, Oregon, USA
Information collection and data processing:  CCM     For more information, please contact us
KeyGene and Floragenex extend license agreement around KeyGene’sSequence Based GenotypingtechnologyKeyGene and Floragenex extend license agreement around KeyGene’sSequence Based Genotypingtechnology" title="Share this link on Facebook">Wageningen, The Netherlands andPortland, Oregon, USAJuly 28, 2015Keygene N.V. and Floragenex Inc. announced today that they have entered into an extended license agreementaround KeyGene’s Sequence Based Genotyping (SBG) technology. The agreement enables Floragenex to extend itsSBG service offerings to include ddRAD-Seq in noncommercialand academic research across all species. Theagreement further cements KeyGene’s SBG technology licensing portfolio and advances Floragenex’s position as aservices leader in fractional genomic sequencing applications. Financial terms of the agreement were not disclosed.“KeyGene is very pleased to strengthen its relationship with Floragenex through this extended SBG licenseagreement”, said Michiel van Eijk, CSO of KeyGene. “Floragenex’ expertise, professionalism and impressive trackrecord with RAD-Seq across a wide range of genomes logically fit with a broader portfolio of SBG serviceofferings. This will accelerate the understanding of genetic variation in plants, animals and other organisms in ahighly cost-efficient manner.”“As one of the earliest companies to utilize next-gen DNA sequencing for genotyping studies, Floragenex is pleasedto now offer clients additional capabilities around SBG and ddRAD-Seq”, said Rick Nipper, the President ofFloragenex. “Our genomics team looks forward to providing support for SBG projects and continuing our strongtradition of assisting the research and life sciences community”.About FloragenexOregon-based Floragenex is a privately owned biotechnology company providing innovative solutions for genomicanalysis in human, plant and animal systems. Since 2007, Floragenex has delivered impact results in hundreds ofgenomics studies focused on answering fundamental questions in genetics, ecology, evolutionary biology andbiomedical research. With multiple offices located on the US Pacific coast, Floragenex technologies permitinvestigation of genomes at unprecedented levels for academic, governmental and commercial researchersworldwide.About KeyGeneThe crop innovation companyKeyGene is a privately owned Ag Biotech company with a primary focus on crop innovation. KeyGene’s approachis to enable molecular genetics for the future of global agriculture. KeyGene supports its strategic partners withcutting edge breeding technologies, bioinformatics and plant-based trait platforms, with more than 135 employeesfrom all over the world. KeyGene has sites in Wageningen, the Netherlands and in Rockville, USA.More news from:. Keygene NV. Floragenex, Inc.Website: http://www.cnchemicals.com/: July 28, 2015The news item on this page is copyright by the organization where it originatedFair use notice